Evidence map›Paper›PMID 39115724›Full record

ArticleBreast cancer research and treatment2024

Correction: The novel TP53 3'-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection.

Feng Zeng, Jianfu Heng, Xinwu Guo, Yue Wang, Wenhan Wu, Lili Tang, Min Chen, Shouman Wang, Hongyu Deng, Jun Wang

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Breast cancer research and treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Feng ZengDepartment of Emergency, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Jianfu HengHunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, 410013, China.
Xinwu GuoSansure Biotech Inc., Changsha, 410205, Hunan, China.
Yue WangSchool of Life Sciences, Central South University, Changsha, 410013, Hunan, China.
Wenhan WuSchool of Life Sciences, Central South University, Changsha, 410013, Hunan, China.
Lili TangDepartment of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Min ChenSansure Biotech Inc., Changsha, 410205, Hunan, China.
Shouman WangDepartment of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Hongyu DengHunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, 410013, China.
Jun WangSchool of Life Sciences, Central South University, Changsha, 410013, Hunan, China. junwang@csu.edu.cn.ORCID https://orcid.org/0000-0001-8008-4563

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39115724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.